Literature DB >> 19550078

Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan.

Eijun Nishihara1, Nobuyuki Amino, Kayoko Maekawa, Hiroshi Yoshida, Mitsuru Ito, Sumihisa Kubota, Shuji Fukata, Akira Miyauchi.   

Abstract

Somatic mutations of the thyrotropin receptor (TSHR) gene and the gene encoding the alpha subunit of the stimulatory GTP-binding protein (Gsalpha) are the main cause for autonomously functioning thyroid nodules (AFTN) in iodine-deficient regions of the world. In iodine-sufficient regions, including Japan, the genetic relevance of AFTN is unclear. In a series of 45 Japanese subjects with AFTN, exons 9 and 10 of the TSHR and exons 7-10 of Gsalpha , where the activating mutations have been found, were analyzed using direct sequencing. We found 29 somatic mutations: 22 in the TSHR gene and 7 in the Gsalpha gene. The most frequent mutation in TSHR was Met453Thr (10 cases), followed by clustered residues from codons 630 through 633 on TSHR (7 cases). Mutations of Gsalpha were detected at codon 201 in 5 cases and at codon 227 in 2 cases. No patients had coexistent TSHR and Gsalpha mutations in the same nodule. All mutated residues but one, which was deleted at codon 403 on the TSHR gene, are constitutively active. The prevalences of a germline polymorphism of Asp727Glu on the TSHR gene and incidental papillary thyroid carcinoma in thyroid surgical specimens were similar to those reported in other studies. In the present study, more than half of the cases with AFTN had a somatic activating mutation either of the TSHR or Gsalpha gene, despite their high iodine intake.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550078     DOI: 10.1507/endocrj.k09e-073

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  10 in total

1.  Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity.

Authors:  Eijun Nishihara; Chun-Rong Chen; Takuya Higashiyama; Yumiko Mizutori-Sasai; Mitsuru Ito; Sumihisa Kubota; Nobuyuki Amino; Akira Miyauchi; Basil Rapoport
Journal:  Thyroid       Date:  2010-10-07       Impact factor: 6.568

2.  Deletion of thyrotropin receptor residue Asp403 in a hyperfunctioning thyroid nodule provides insight into the role of the ectodomain in ligand-induced receptor activation.

Authors:  E Nishihara; C-R Chen; Y Mizutori-Sasai; M Ito; S Kubota; N Amino; A Miyauchi; B Rapoport
Journal:  J Endocrinol Invest       Date:  2011-05-19       Impact factor: 4.256

Review 3.  Molecular approaches to thyroid cancer diagnosis.

Authors:  Susan J Hsiao; Yuri E Nikiforov
Journal:  Endocr Relat Cancer       Date:  2014-05-14       Impact factor: 5.678

4.  Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

Authors:  Marco Dal Molin; Hanno Matthaei; Jian Wu; Amanda Blackford; Marija Debeljak; Neda Rezaee; Christopher L Wolfgang; Giovanni Butturini; Roberto Salvia; Claudio Bassi; Michael G Goggins; Kenneth W Kinzler; Bert Vogelstein; James R Eshleman; Ralph H Hruban; Anirban Maitra
Journal:  Ann Surg Oncol       Date:  2013-07-12       Impact factor: 5.344

5.  Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.

Authors:  Marina N Nikiforova; Abigail I Wald; Somak Roy; Mary Beth Durso; Yuri E Nikiforov
Journal:  J Clin Endocrinol Metab       Date:  2013-08-26       Impact factor: 5.958

6.  Follicular thyroid carcinoma with NRAS Q61K and GNAS R201H mutations that had a good (131)I treatment response.

Authors:  Jin-Ying Lu; Po-Ju Hung; Pei-Lung Chen; Ruoh-Fang Yen; Kuan-Ting Kuo; Tsung-Lin Yang; Chih-Yuan Wang; Tien-Chun Chang; Tien-Shang Huang; Ching-Chung Chang
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-01-05

7.  Oncogenesis of Thyroid Cancer

Authors:  Enas Younis
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

8.  Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.

Authors:  Lianghong Teng; Wanglong Deng; Junliang Lu; Jing Zhang; Xinyu Ren; Huanli Duan; Shannon Chuai; Feidie Duan; Wei Gao; Tao Lu; Huanwen Wu; Zhiyong Liang
Journal:  Oncotarget       Date:  2017-03-28

9.  Inherited variants in genes somatically mutated in thyroid cancer.

Authors:  Chiara Campo; Aleksandra Köhler; Gisella Figlioli; Rossella Elisei; Cristina Romei; Monica Cipollini; Franco Bambi; Kari Hemminki; Federica Gemignani; Stefano Landi; Asta Försti
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

10.  Clinical Significance of Thyroid-Stimulating Hormone Receptor Gene Mutations and/or Sodium-Iodine Symporter Gene Overexpression in Indeterminate Thyroid Fine Needle Biopsies.

Authors:  Haixia Guan; Danielle Matonis; Gianluca Toraldo; Stephanie L Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-25       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.